Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

13 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A retrospective chart review to assess feeding tolerance in children who had been switched from an intact protein formula to a Peptide based formula due to feeding intolerance in a pediatric facility for the developmentally delayed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula

NCT03048409

Enteral Feeding Intolerance

COMPLETED

Acceptability, Gastro Intestinal Tolerance Compliance of a Paediatric Tube-feed Formula Derived From Food for Children

NCT03718195

Child Nutrition Disorders

COMPLETED NA

Acceptability and Tolerance Study of a Low Calorie Peptide Based Paediatric Tube Feed Formula.

NCT03718208

Cerebral Palsy

COMPLETED NA

Feeding Trial in Pediatric Patients

NCT01469117

Developmental Disabilities

COMPLETED

Feeding Intolerance in Formula-Fed Infants

NCT02028156

Feeding Intolerance

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Medical records of pediatric patients with enteral feeding intolerance on standard polymeric formulas that were switched to a peptide based formula will be retrospectively analyzed. Data will be collected on caloric intake, ability to meet enteral nutrition goals, incidence of intolerance, and the use of medications to control gastrointestinal symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Developmental Disabilities Feeding Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 13 months to \< 18 years of age on admission to facility
* Required enteral nutrition to meet 90% or more of their energy needs prior to switch to a Peptide based formula
* Received enteral nutrition with an intact protein formula for a minimum of two weeks prior to a switch to a Peptide based formula
* Have documentation of intolerance to an intact protein formula, followed by a switch in formula received to a Peptide based formula
* Have documentation of an assessment of feeding tolerance following the switch to a Peptide based formula
* Formulas received must be indicated for use in children or adults (not infant formulas).

Exclusion Criteria

* Recent abdominal surgery, change in tube position/placement (within past 30 days)
* Cow's milk protein allergy
* Any current infections including upper respiratory, viral, gastroenteritis, wound infection.

Minimum Eligible Age

13 Months

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No